S&P 500   3,236.92 (-2.37%)
DOW   26,763.13 (-1.92%)
QQQ   263.47 (-3.31%)
AAPL   107.83 (-3.56%)
MSFT   201.68 (-2.77%)
FB   250.10 (-1.83%)
GOOGL   1,412.54 (-3.24%)
AMZN   3,010.57 (-3.78%)
NVDA   488.42 (-3.38%)
TSLA   384.50 (-9.37%)
BABA   273.07 (-0.81%)
CGC   14.60 (-8.98%)
GE   6.13 (-1.92%)
MU   50.10 (+0.80%)
AMD   75.15 (-3.28%)
T   27.92 (-2.07%)
F   6.67 (-1.62%)
ACB   5.17 (-29.37%)
GILD   63.18 (-0.35%)
NFLX   472.07 (-3.89%)
DIS   123.41 (-2.99%)
BAC   23.36 (-2.42%)
BA   152.08 (-3.01%)
S&P 500   3,236.92 (-2.37%)
DOW   26,763.13 (-1.92%)
QQQ   263.47 (-3.31%)
AAPL   107.83 (-3.56%)
MSFT   201.68 (-2.77%)
FB   250.10 (-1.83%)
GOOGL   1,412.54 (-3.24%)
AMZN   3,010.57 (-3.78%)
NVDA   488.42 (-3.38%)
TSLA   384.50 (-9.37%)
BABA   273.07 (-0.81%)
CGC   14.60 (-8.98%)
GE   6.13 (-1.92%)
MU   50.10 (+0.80%)
AMD   75.15 (-3.28%)
T   27.92 (-2.07%)
F   6.67 (-1.62%)
ACB   5.17 (-29.37%)
GILD   63.18 (-0.35%)
NFLX   472.07 (-3.89%)
DIS   123.41 (-2.99%)
BAC   23.36 (-2.42%)
BA   152.08 (-3.01%)
S&P 500   3,236.92 (-2.37%)
DOW   26,763.13 (-1.92%)
QQQ   263.47 (-3.31%)
AAPL   107.83 (-3.56%)
MSFT   201.68 (-2.77%)
FB   250.10 (-1.83%)
GOOGL   1,412.54 (-3.24%)
AMZN   3,010.57 (-3.78%)
NVDA   488.42 (-3.38%)
TSLA   384.50 (-9.37%)
BABA   273.07 (-0.81%)
CGC   14.60 (-8.98%)
GE   6.13 (-1.92%)
MU   50.10 (+0.80%)
AMD   75.15 (-3.28%)
T   27.92 (-2.07%)
F   6.67 (-1.62%)
ACB   5.17 (-29.37%)
GILD   63.18 (-0.35%)
NFLX   472.07 (-3.89%)
DIS   123.41 (-2.99%)
BAC   23.36 (-2.42%)
BA   152.08 (-3.01%)
S&P 500   3,236.92 (-2.37%)
DOW   26,763.13 (-1.92%)
QQQ   263.47 (-3.31%)
AAPL   107.83 (-3.56%)
MSFT   201.68 (-2.77%)
FB   250.10 (-1.83%)
GOOGL   1,412.54 (-3.24%)
AMZN   3,010.57 (-3.78%)
NVDA   488.42 (-3.38%)
TSLA   384.50 (-9.37%)
BABA   273.07 (-0.81%)
CGC   14.60 (-8.98%)
GE   6.13 (-1.92%)
MU   50.10 (+0.80%)
AMD   75.15 (-3.28%)
T   27.92 (-2.07%)
F   6.67 (-1.62%)
ACB   5.17 (-29.37%)
GILD   63.18 (-0.35%)
NFLX   472.07 (-3.89%)
DIS   123.41 (-2.99%)
BAC   23.36 (-2.42%)
BA   152.08 (-3.01%)
Log in
NASDAQ:TLRY

Tilray Stock Forecast, Price & News

$4.71
-0.65 (-12.13 %)
(As of 09/23/2020 03:52 PM ET)
Add
Compare
Today's Range
$4.71
Now: $4.71
$5.19
50-Day Range
$5.00
MA: $6.47
$8.70
52-Week Range
$2.43
Now: $4.71
$29.50
Volume329,660 shs
Average Volume8.49 million shs
Market Capitalization$599.01 million
P/E RatioN/A
Dividend YieldN/A
Beta2.92
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.
Read More
Tilray logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.39 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TLRY
CUSIPN/A
CIKN/A
Phone206-432-9325

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$166.98 million
Book Value$2.78 per share

Profitability

Net Income$-321,170,000.00
Net Margins-259.60%

Miscellaneous

Employees1,646
Market Cap$599.01 million
Next Earnings Date11/10/2020 (Estimated)
OptionableOptionable
$4.71
-0.65 (-12.13 %)
(As of 09/23/2020 03:52 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TLRY News and Ratings via Email

Sign-up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tilray (NASDAQ:TLRY) Frequently Asked Questions

How has Tilray's stock price been impacted by COVID-19 (Coronavirus)?

Tilray's stock was trading at $7.09 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TLRY shares have decreased by 33.6% and is now trading at $4.71.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Tilray?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last year. There are currently 1 sell rating, 12 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Tilray
.

When is Tilray's next earnings date?

Tilray is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Tilray
.

How were Tilray's earnings last quarter?

Tilray Inc (NASDAQ:TLRY) issued its quarterly earnings data on Monday, August, 10th. The company reported ($0.65) EPS for the quarter, missing the Zacks' consensus estimate of ($0.27) by $0.38. The firm earned $50.41 million during the quarter, compared to the consensus estimate of $54.99 million. Tilray had a negative return on equity of 77.77% and a negative net margin of 259.60%. The company's revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.32) earnings per share.
View Tilray's earnings history
.

What price target have analysts set for TLRY?

15 equities research analysts have issued 1 year price objectives for Tilray's stock. Their forecasts range from $4.00 to $31.00. On average, they expect Tilray's share price to reach $12.91 in the next year. This suggests a possible upside of 174.1% from the stock's current price.
View analysts' price targets for Tilray
.

Are investors shorting Tilray?

Tilray saw a decrease in short interest in August. As of August 31st, there was short interest totaling 17,270,000 shares, a decrease of 22.6% from the August 15th total of 22,300,000 shares. Based on an average daily trading volume, of 6,180,000 shares, the days-to-cover ratio is currently 2.8 days.
View Tilray's Short Interest
.

Who are some of Tilray's key competitors?

What other stocks do shareholders of Tilray own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilray investors own include Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Micron Technology (MU), Netflix (NFLX), Tesla (TSLA) and Aphria (APHA).

Who are Tilray's key executives?

Tilray's management team includes the following people:
  • Mr. Edward Wood Pastorius Jr., Chief Revenue Officer (Age 50)
  • Mr. Brendan Kennedy, Pres, CEO & Director (Age 46)
  • Mr. Mark Castaneda, CFO, Sec. & Treasurer (Age 53)
  • Dr. Catherine Jacobson, Director of Clinical Research & Member of Medical Advisory Board

When did Tilray IPO?

(TLRY) raised $135 million in an initial public offering on Thursday, July 19th 2018. The company issued 9,000,000 shares at a price of $14.00-$16.00 per share. Cowen and Company served as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

What is Tilray's stock symbol?

Tilray trades on the NASDAQ under the ticker symbol "TLRY."

Who are Tilray's major shareholders?

Tilray's stock is owned by a number of retail and institutional investors. Top institutional investors include Think Investments LP (0.88%), Anson Funds Management LP (0.64%), California Public Employees Retirement System (0.16%), Princeton Global Asset Management LLC (0.13%), Virtu Financial LLC (0.11%) and Advisor Group Holdings Inc. (0.09%). Company insiders that own Tilray stock include Brendan Kennedy, Christine StClare, Edward Wood Pastorius Jr, Mark Castaneda, Maryscott Greenwood and Michael Auerbach.
View institutional ownership trends for Tilray
.

Which institutional investors are selling Tilray stock?

TLRY stock was sold by a variety of institutional investors in the last quarter, including Anson Funds Management LP, and AdvisorShares Investments LLC. Company insiders that have sold Tilray company stock in the last year include Brendan Kennedy, Maryscott Greenwood, and Michael Auerbach.
View insider buying and selling activity for Tilray
.

Which institutional investors are buying Tilray stock?

TLRY stock was bought by a variety of institutional investors in the last quarter, including Think Investments LP, Princeton Global Asset Management LLC, California Public Employees Retirement System, Virtu Financial LLC, Requisite Capital Management LLC, Bridges Investment Management Inc., Advisor Group Holdings Inc., and Leap Investments LP.
View insider buying and selling activity for Tilray
.

How do I buy shares of Tilray?

Shares of TLRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tilray's stock price today?

One share of TLRY stock can currently be purchased for approximately $4.71.

How big of a company is Tilray?

Tilray has a market capitalization of $599.01 million and generates $166.98 million in revenue each year. The company earns $-321,170,000.00 in net income (profit) each year or ($1.69) on an earnings per share basis. Tilray employs 1,646 workers across the globe.

What is Tilray's official website?

The official website for Tilray is www.tilray.com.

How can I contact Tilray?

Tilray's mailing address is 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2. The company can be reached via phone at 206-432-9325.

This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.